Medical Condition News

RSS

Problems patients experience due to dental or skin conditions often misunderstood by care providers

Problems patients experience due to dental or skin conditions are often differently perceived by care providers. This is shown in a dissertation by Francesca Sampogna, a researcher in epidemiology at Istituto Dermopatico dell'Immacolata in Rome.

31 May 2010

Cook Medical launches BIGopsy Backloading Biopsy Forceps for accurate diagnosis of kidney cancers

Urologists treating patients with suspicious ureteral or kidney lesions now have a tool to help them more effectively make diagnoses. Cook Medical has introduced the BIGopsy Backloading Biopsy Forceps, a device designed and engineered to obtain large renal or ureteral tissue specimens up to 4 mm3 for cancer diagnosis. The larger sample size helps produce biopsy results without the need for repeat tissue-sampling procedures associated with other biopsy devices.

31 May 2010

Ontario's doctors call for renewed effort in fight against tobacco

This World No Tobacco Day, Ontario's doctors are calling for renewed efforts to reduce the total number of smokers in Ontario. While the current government has shown leadership by implementing a number of initiatives to help reduce the use of tobacco and second hand smoke, there is still more work to be done.

31 May 2010

Amorfix provides update on development of blood test for vCJD

Amorfix Life Sciences, a company focused on treatments and diagnostics for misfolded protein diseases, provides an update on the development of a blood test for vCJD, one of its six product development programs.

31 May 2010

New Brunswick's economic cost of diabetes to increase to $427M by 2020, if left unchecked

In a speech given today in Fredericton, the Canadian Diabetes Association released preliminary data from a diabetes cost model developed for the province of New Brunswick. The New Brunswick Diabetes Cost Model found that both the cost and prevalence of diabetes in the province are at dramatically high levels and it is expected that this burden will continue to elevate over the next decade.

31 May 2010

New links discovered between Paul Klee's work and his 'scleroderma'

In 1933 Paul Klee's work was branded as 'Entartete Kunst' (Degenerate Art) by the National Socialists and he was dismissed from his professorial post at the Düsseldorf Academy of Fine Arts. This led him, together with his wife Lily, to return to his 'real home' of Bern. Here his avant-garde art was not understood and Klee found himself in unasked for isolation. In 1935 Klee started to suffer from a mysterious disease. The symptoms included changes to the skin and problems with the internal organs.

31 May 2010

Education slows down development of dementia: Researchers

Researchers have discovered that education not only delays the early symptoms of dementia, but can also slow down the development of the disease - a finding that could result in faster diagnosis and treatment of dementia, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

31 May 2010

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.

From CSL Ltd 31 May 2010

Deep-brain stimulation makes difference in the lives of people with Parkinson disease

A surgical treatment that stimulates distressed neural networks through electrodes threaded directly into a person's brain has quietly made a difference in the lives of tens of thousands of people with Parkinson disease, essential tremor, and dystonia over the course of the past decade. But while it steadies patients' shaking limbs with surprising effect, its benefits on some patients' minds and personal lives have been more mixed.

31 May 2010

Epilepsy surgery ends seizures and prevents further deterioration in memory

Patients with drug-resistant epilepsy run the risk of gradual deterioration in their cognitive abilities. Surgical treatment generally puts an end to seizures but can have a negative effect on memory. However, there is no further deterioration in memory, and some patients may even recover some of their memory capacity, reveals a thesis from the University of Gothenburg.

31 May 2010

Alzheimer's disease awareness event aims to raise over $100,000 for Alzheimer Society of Montreal

It's on a path full of history and collective memories that more than 500 walkers will gather, on Sunday, May 30th, for the fourth edition of the RONA Walk for Memories. This Alzheimer's disease awareness event, which will take place on the Quays of the Old Port and in the streets of the Old Montreal, aims to raise over $100,000 for the Alzheimer Society of Montreal!

31 May 2010

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

A two-year, $12 million contract with the U.S. Department of Defense Office of Technology Transition (OTT) will jumpstart human trials of three innovative research programs that aim to replace scars and defects with healthy, functional tissues, announced officials of the University of Pittsburgh and the McGowan Institute for Regenerative Medicine today at the Institute's Second Annual Open Session, Soldiers and Sailors Memorial Hall, Oakland.

31 May 2010

IMRT avoids xerostomia, but effectiveness on controlling cancer unclear

An advanced type of cancer radiation is more successful than traditional radiation in avoiding "dry mouth" when treating head and neck cancers, but it is unknown whether the treatment is better or worse at reducing the size of tumors, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality.

31 May 2010

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

Researchers have identified a distinct pattern of gene expression in the largest reported group of kidney transplant recipients who have not rejected the transplant kidneys even though they stopped taking anti-rejection drugs. This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy. In 2008, more than 80,000 people in the United States were living with a kidney transplant.

31 May 2010

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Physician-scientists from NewYork-Presbyterian Hospital/Columbia University Medical Center will present their latest research findings at the American Urological Association Annual Meeting in San Francisco, May 29 to June 3.

31 May 2010

Athletic mouthguards reduce incidence and severity of dental injury

If you participate in organized sports or recreational activities, there's always the risk of injury to the mouth, says the American Dental Association (ADA).

31 May 2010

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Celladon Corp., a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, today announced that six-month data from its Phase 2 clinical trial of MYDICAR® show improvements in clinical outcomes and disease markers in advanced heart failure patients treated with the genetically targeted enzyme replacement therapy.

31 May 2010

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

Scientists from Singapore, China and USA have identified three new susceptibility genes in a genome-wide association study of nasopharyngeal carcinoma (NPC). The study, led by the Genome Institute of Singapore (GIS), a biomedical research institute of the Agency for Science, Technology and Research (A*STAR), and the Sun Yat-Sen University Cancer Centre, identified genetic risk factors of NPC that advance the understanding of the important role played by host genetic variation in influencing the susceptibility to this cancer.

31 May 2010

Researchers identify body's natural self-repair mechanism that kicks in after spinal-cord injury

Researchers in the University of Alberta's Faculty of Rehabilitation Medicine have made an important discovery that could lead to more effective treatments for spinal-cord injuries. Karim Fouad and David Bennett have identified one of the body's natural self-repair mechanisms that kick in after injury.

31 May 2010

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

Targeted Genetics Corporation announced that its partner, Celladon Corporation, presented full data today that show the first Phase II trial with MYDICAR® for the treatment of advanced heart failure has met its primary safety and efficacy endpoints, as prospectively defined in the Phase II trial protocol.

31 May 2010

Medical Condition News

Problems patients experience due to dental or skin conditions often misunderstood by care providers

Cook Medical launches BIGopsy Backloading Biopsy Forceps for accurate diagnosis of kidney cancers

Ontario's doctors call for renewed effort in fight against tobacco

Amorfix provides update on development of blood test for vCJD

New Brunswick's economic cost of diabetes to increase to $427M by 2020, if left unchecked

New links discovered between Paul Klee's work and his 'scleroderma'

Education slows down development of dementia: Researchers

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

Deep-brain stimulation makes difference in the lives of people with Parkinson disease

Epilepsy surgery ends seizures and prevents further deterioration in memory

Alzheimer's disease awareness event aims to raise over $100,000 for Alzheimer Society of Montreal

U.S. Department of Defense OTT initiative to replace scars and defects with healthy, functional tissues

IMRT avoids xerostomia, but effectiveness on controlling cancer unclear

Researchers identify pattern of gene expression in kidney transplant recipients who don't need anti-rejection drugs

NewYork-Presbyterian Hospital/Columbia University Medical Center announce presentations at American Urological Association meeting

Athletic mouthguards reduce incidence and severity of dental injury

Celladon announces 6-month data from Phase 2 clinical trial of MYDICAR in advanced heart failure patients

Scientists identify new susceptibility genes in genome-wide association study of nasopharyngeal carcinoma

Researchers identify body's natural self-repair mechanism that kicks in after spinal-cord injury

Targeted Genetics's partner Celladon presents Phase II trial data with MYDICAR at Heart Failure Congress 2010

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News